Diagnostic microbiology and infectious disease · 2024
Respiratory syncytial virus: Characteristics, complications and mortality in immunocompetent versus immunocompromised hospitalized adults in Northern Denmark.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hagen Trine Langfeldt, Nitschke Mette Juul, Smit Jesper
Аннотация
BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly well-known cause of severe respiratory symptoms in adults. We aimed to describe characteristics, complications and in-hospital mortality of adults admitted to hospital with RSV-related respiratory symptoms.
METHODS: Data were collected from electronic health records in the North Denmark Region for hospitalized adults diagnosed with RSV between April 1st - December 31st 2021. We collected data on characteristics, complications and mortality. Results were compared between immunocompromised and -competent patients.
RESULTS: We included 111 patients. Sixty-five percent had comorbidities and 20 % received immunosuppressive drugs. Fifty-three percent had bacterial pneumonia and 61 % needed oxygen support. Mortality was 12 %. There were no differences in complications between the compared groups.
CONCLUSION: Severe respiratory symptoms were frequent among RSV-patients. Bacterial co-infections were common in the study population and mortality was considerable, regardless of known immunosuppression, thus warranting thorough and early investigations in RSV-positive patients.
METHODS: Data were collected from electronic health records in the North Denmark Region for hospitalized adults diagnosed with RSV between April 1st - December 31st 2021. We collected data on characteristics, complications and mortality. Results were compared between immunocompromised and -competent patients.
RESULTS: We included 111 patients. Sixty-five percent had comorbidities and 20 % received immunosuppressive drugs. Fifty-three percent had bacterial pneumonia and 61 % needed oxygen support. Mortality was 12 %. There were no differences in complications between the compared groups.
CONCLUSION: Severe respiratory symptoms were frequent among RSV-patients. Bacterial co-infections were common in the study population and mortality was considerable, regardless of known immunosuppression, thus warranting thorough and early investigations in RSV-positive patients.